A recent study based in India by Ojasveda herbals indicates promising results from Adenosine therapy. New Delhi, September 29, 2022: India-based nutraceutical firm, Ojasveda has put together a research inclusive study about how the introduction of adenosine therapy can be revolutionary for chronic respiratory diseases like tuberculosis, lung fibrosis, asthma, and such. For the Adenosine therapy, the study proposed an…
